ORIC Pharmaceuticals Inc.
ORIC | NASDAQ
$12.67
-$0.12 (-0.94%)
At close: Sep 21, 2026, 4:00 PM ET
$12.76
+$0.09 (+0.71%)
Pre-market:
Sep 22, 2026, 8:26 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.22M | 1.11M | 1.03M | n/a | n/a | n/a |
Gross Profit | -1.22M | -1.11M | -1.03M | n/a | n/a | n/a |
Operating Income | -143M | -142.9M | -110.78M | -91.77M | -78.87M | -74.19M |
Interest Income | n/a | n/a | 10.08M | 2.65M | 141K | 306K |
Pretax Income | -129.47M | -127.85M | -100.7M | -89.12M | -78.72M | -73.7M |
Net Income | -129.47M | -127.85M | -100.7M | -89.12M | -78.72M | -73.7M |
Selling & General & Admin | 33.19M | 28.82M | 25.61M | 25.09M | 22.01M | 13.42M |
Research & Development | 109.82M | 114.07M | 85.17M | 61.68M | 56.86M | 60.76M |
Other Expenses | -1.22M | -1.11M | -1.03M | 5M | n/a | n/a |
Operating Expenses | 141.78M | 141.79M | 109.75M | 91.77M | 78.87M | 74.19M |
Interest Expense | n/a | n/a | n/a | 2.65M | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 143M | 142.9M | 110.78M | 91.77M | 78.87M | 74.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 87.79M | 69.73M | 51.45M | 39.66M | 37.95M | 21.94M |
Shares Outstanding (Diluted) | 87.79M | 69.73M | 51.45M | 39.66M | 37.95M | 21.94M |
EPS (Basic) | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
EPS (Diluted) | -1.47 | -1.83 | -1.96 | -2.25 | -2.07 | -3.36 |
EBITDA | -128.25M | -126.74M | -99.67M | -85.8M | -77.82M | -48.37M |
EBIT | -129.47M | -127.85M | -100.7M | -86.77M | -78.72M | -49.34M |
Depreciation & Amortization | 1.22M | 1.11M | 1.03M | 966K | 897K | 970K |
Add to Watchlist
Select watchlists to add or remove ORIC